Insider Selling: Addus HomeCare Co. (NASDAQ:ADUS) Director Sells 500 Shares of Stock

Addus HomeCare Co. (NASDAQ:ADUS) Director Esteban Lopez sold 500 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the transaction, the director now directly owns 3,866 shares in the company, valued at approximately $502,695.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Addus HomeCare Price Performance

ADUS traded down $3.21 during trading on Friday, reaching $126.37. 106,021 shares of the stock were exchanged, compared to its average volume of 134,223. The business’s 50 day moving average price is $124.44 and its two-hundred day moving average price is $111.15. Addus HomeCare Co. has a 1 year low of $78.35 and a 1 year high of $134.78. The company has a market capitalization of $2.29 billion, a price-to-earnings ratio of 31.59, a P/E/G ratio of 2.43 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The business had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The company’s revenue was up 10.4% on a year-over-year basis. During the same period last year, the company posted $0.94 EPS. On average, analysts anticipate that Addus HomeCare Co. will post 4.53 EPS for the current year.

Hedge Funds Weigh In On Addus HomeCare

Large investors have recently bought and sold shares of the stock. Ellsworth Advisors LLC acquired a new stake in Addus HomeCare during the 2nd quarter valued at approximately $598,000. Dean Capital Management acquired a new position in Addus HomeCare during the 4th quarter worth $652,000. Quadrature Capital Ltd acquired a new position in Addus HomeCare in the first quarter worth about $1,557,000. Lord Abbett & CO. LLC bought a new stake in Addus HomeCare in the first quarter valued at about $8,274,000. Finally, Vanguard Group Inc. raised its stake in Addus HomeCare by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 1,257,440 shares of the company’s stock valued at $116,753,000 after buying an additional 38,876 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on ADUS shares. TD Cowen boosted their target price on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Macquarie started coverage on shares of Addus HomeCare in a report on Friday, June 28th. They issued an “outperform” rating and a $136.00 price objective for the company. StockNews.com downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $141.00 price target on shares of Addus HomeCare in a research report on Tuesday. Finally, Oppenheimer increased their price objective on Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 7th. One analyst has rated the stock with a sell rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Moderate Buy” and a consensus price target of $127.57.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.